Title of article :
Dipeptidyl peptidase IV inhibitors derived from β-aminoacylpiperidines bearing a fused thiazole, oxazole, isoxazole, or pyrazole
Author/Authors :
Wallace T. Ashton، نويسنده , , Rosemary M. Sisco، نويسنده , , Yu-Hong Dong، نويسنده , , Kathryn A. Lyons، نويسنده , , Huaibing He، نويسنده , , George A. Doss، نويسنده , , Barbara Leiting، نويسنده , , Reshma A. Patel، نويسنده , , Joseph K. Wu، نويسنده , , Frank Marsilio، نويسنده , , Nancy A. Thornberry، نويسنده , , Ann E. Weber، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2005
Pages :
6
From page :
2253
To page :
2258
Abstract :
A series of β-aminoacylpiperidines bearing various fused five-membered heterocyclic rings was synthesized as dipeptidyl peptidase IV inhibitors. Potent and relatively selective inhibition could be obtained, depending on choice of heterocycle, regioisomerism, and substitution. In particular, one analog (74, DPP-IV IC50 = 26 nM) exhibited good oral bioavailability and acceptable half-life in the rat, albeit with rather high clearance.
Keywords :
Dipeptidyl peptidase IV inhibitors , Diabetes
Journal title :
Bioorganic & Medicinal Chemistry Letters
Serial Year :
2005
Journal title :
Bioorganic & Medicinal Chemistry Letters
Record number :
795568
Link To Document :
بازگشت